Optometrists in Port Saint Lucie, FL Accepting Medicare
6 Optometrists found. Showing 1 - 6
 Cho Vision Group Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7582 S Federal Hwy, Port Saint Lucie, FL 34952 Phone: 303-817-8912 |
 Philip Desantis, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1850 Sw Gatlin Blvd, Walmart Optical, Port Saint Lucie, FL 34953 Phone: 772-343-0003 Fax: 772-336-9017 |
L.c. Erbe O.d. P.a. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1721 Sw Gatlin Blvd, Port Saint Lucie, FL 34953 Phone: 772-873-0037 |
Dr. John Patrick Gallagher Jr., OD Optometrist Medicare: Medicare Enrolled Practice Location: 826 Se Carnival Ave, Port Saint Lucie, FL 34983 Phone: 772-812-0727 |
 Dr. Tulsi Patel, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1477 North West Port Saint Lucie West Boulevard, Suite 105, Port Saint Lucie, FL 34986 Phone: 772-446-8715 |
William A Olivos Od Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2710 Sw Port St Lucie Blvd, Port Saint Lucie, FL 34953 Phone: 772-460-8487 Fax: 772-460-0225 |
News Archive
UCSF scientists elected as members of National Academy of Sciences for excellence in biomedical research
Alexander D. Johnson, PhD, and Shinya Yamanaka, MD, PhD, have been elected as members of the National Academy of Sciences for their excellence in original scientific research. It is one of the highest honors bestowed on a scientist or engineer in the United States.
Louisville researchers move closer to potential treatment for gum disease
University of Louisville researchers recently received a patent on a synthetic biochemical compound and its variants, moving science closer to a treatment for gum disease. This discovery could lead to the formulation of a mouth rinse or tooth varnish to prevent the pathogen, P. gingivalis from colonizing in the mouth and establishing itself orally.
Gastroenterology journal publishes results of Lexicon LX1031 Phase 2 trial in IBS
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that results from the Phase 2 clinical trial of LX1031 in patients with non-constipating irritable bowel syndrome (IBS) were published earlier this week in the August 2011 edition of the journal Gastroenterology.
New microbial genes responsible for bile acid conversion is a major step forward for gut health
As the owner of a human body, you're carrying trillions of microbes with you everywhere you go. These microscopic organisms aren't just hitching a ride; many of them perform essential chemical reactions that regulate everything from our digestion to our immune system to our moods.
› Verified 4 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Occupational Therapists
Podiatrists
Optometrists
Audiologists